Cutting AIDS funding to China will “be a big mistake for a donor and particularly, for anyone who’s invested in China today, … for the simple reason that this funding is a catalytic fund,” UNAIDS Executive Director Michel Sidibe told Reuters in an interview on Monday.
NIH announced on Monday it will provide $70 million over five years to three collaborations searching for an HIV/AIDS cure, making it “the largest single investment yet … into finding a way to rid the virus from the body or at least reduce levels to the point that infected people can stop taking anti-HIV drugs â€“ which many researchers until recently viewed as a hopeless quest,” ScienceInsider reports (Cohen, 7/11).
Significant progress is being made toward reaching the Millennium Development Goals (MDGs) by the 2015 deadline, but the poorest countries are not progressing as quickly and more must be done to improve health and development outcomes in those nations, according to this year’s MDG report (.pdf), VOA News reports. “Despite the global economic downturn and the food and energy crises, we are on track to meet the MDG targets for poverty-reduction,” U.N. Secretary General Ban Ki-moon said at the launch of the report on Thursday in Geneva (Schlein, 7/7).
“India will not compromise on drug licensing norms and [will] continue to produce generic drugs for free treatment to HIV-positive patients, Commerce and Industry Minister Anand Sharma said” on Wednesday, the IANS/Times of India reports.
“A federal appeals court has ruled that the United States cannot force partners in its international fight against AIDS to denounce prostitution as a condition for receiving funding,” the Associated Press reports. Three health organizations sued the government in 2005, saying some groups “advocate for a reduction in penalties for prostitution to prevent interference with outreach efforts,” according to the news agency (7/6).
“Now, we are in the Third-Generation of AIDS programming, in which the focus must be on a sustainable health systems response, especially in the countries most affected by HIV & AIDS,” Jonathan Quick, president and CEO of Management Sciences for Health, writes on the organization’s “Global Health Impact” blog. Quick…
Author and journalist Maryn McKenna in her “Superbug” blog on Wired.com examines U.S. spending on drug-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). She examines data presented by Eli Perencevich of the University of Iowa and colleagues at the World HAI Forum, which looked at how much of the National Institute of Allergy and Infectious Diseases’ budget went to the problem of drug-resistant diseases versus other infectious diseases. “They found the answer to be: Not very much,” she writes.
“Freshman Sen. Marco Rubio (R-FL) is becoming an increasingly critical and hawkish voice on the Obama administration’s foreign policy, but he is actually a supporter of U.S. foreign assistance programs and made the case for maintaining this funding to his constituents last week,” Foreign Policy’s “The Cable” blog writes.
With at least five million people worldwide taking antiretroviral therapy for HIV infection, theÂ International Forum for Collaborative HIV Research, in aÂ PLoS Medicine Policy Forum published on Tuesday, “recommends that improved and sustained global drug safety monitoring, including monitoring for substandard products, drug diversion, inappropriate use, and toxicity, is critical,” a…
According to research published Friday in the July 2011 issue of the WHO Bulletin, a new long-range forecasting model suggests global deaths from infectious diseases will decrease by 70 percent by 2060, despite significant growth in population worldwide, CTV.ca reports. Using health statistics and other data, including economic, fertility and…